66 related articles for article (PubMed ID: 32475629)
21. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
[TBL] [Abstract][Full Text] [Related]
22. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
Gut; 2005 Aug; 54(8):1151-6. PubMed ID: 16009687
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
[TBL] [Abstract][Full Text] [Related]
24. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.
Oeda S; Mizuta T; Isoda H; Kuwashiro T; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Ozaki I; Tanaka K; Fujimoto K
Hepatogastroenterology; 2013 Sep; 60(126):1399-404. PubMed ID: 23635508
[TBL] [Abstract][Full Text] [Related]
25. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
Chang YJ; Chen LJ; Chang YJ; Chen PD
Eur J Surg Oncol; 2020 Sep; 46(9):1703-1710. PubMed ID: 32475629
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous local ablation therapy in small hepatocellular carcinoma.
Lin SM; Lin DY
Chang Gung Med J; 2003 May; 26(5):308-14. PubMed ID: 12934846
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
Bouza C; López-Cuadrado T; Alcázar R; Saz-Parkinson Z; Amate JM
BMC Gastroenterol; 2009 May; 9():31. PubMed ID: 19432967
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Schoppmeyer K; Weis S; Mössner J; Fleig WE
Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
Huo TI; Huang YH; Wu JC
J Chin Med Assoc; 2005 Apr; 68(4):155-9. PubMed ID: 15850062
[TBL] [Abstract][Full Text] [Related]
31. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.
Orlando A; Leandro G; Olivo M; Andriulli A; Cottone M
Am J Gastroenterol; 2009 Feb; 104(2):514-24. PubMed ID: 19174803
[TBL] [Abstract][Full Text] [Related]
33. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
